The AI 100 & Combining Artificial Intelligence with Human Intelligence in Drug Development

We at twoXAR were very honored to be included this week in The AI 100, CBInsight’s list of top private Artificial Intelligence companies. It’s given me a chance to reflect on how we employ AI relative to others in the industry.

 Our focus is on drug development — and being one of the few biopharma companies to be included in the list, we use AI in a unique way. Where others may be using AI as the sole ingredient…

READ THE FULL POST AT MEDIUM.COM

Comments are closed.